6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 6 of 6 clinical reviews.
An independent review of Noom's Better Business Bureau rating, FTC complaints, state attorney-general actions, and GLP-1 program oversight, with primary-source citations and a clear framework for evaluating whether Noom is legitimate.
An independent review of Noom's LegitScript status, BBB rating, state licensing, GLP-1 prescribing practices, and clinical evidence. Learn what accreditation signals mean for your safety.
An evidence-based, critical review of Noom's medical leadership, clinical credentials, GLP-1 prescribing model, and regulatory standing. Includes BBB data, FDA compliance notes, and published trial evidence.
An independent, evidence-based review of Noom's GLP-1 prescribing practices, published outcomes data, complaint patterns, and how the platform compares to clinical weight-loss benchmarks.
A critical, data-driven look at Noom's subscription pricing from 2016 to 2024, GLP-1 add-on costs, complaint patterns, and whether the platform delivers clinically meaningful weight loss.
A clinically honest breakdown of which patients should avoid Noom's app-plus-coaching model, including those with eating disorders, serious comorbidities, and expectations of FDA-supervised GLP-1 care.